Page 52 - Eua News Today

La carta de 29 senadors demòcrates demanant un alto el foc, fa uns dies, expressava un inusual malestar públic en el si del partit del president, tradicionalment més proisraelià que els republicans...

AP FILE - In this Feb. 27, 2020, file photo, the DoorDash app is shown on a smartphone in New York. Some app-based delivery companies have announced hiring sprees to cope with a surge in orders from millions of people stuck at home. DoorDash has launched a "priority access program" to help laid off restaurant employees sign up for delivery work. (AP Photo, File) By: Web Staff and last updated 2021-05-19 17:04:42-04 VIRGINIA BEACH, Va. - Did someone order a COVID-19 test? Vault ...

Multiple variants of the virus that causes Covid-19 have been found globally and in India. Here is a look at some of the variants of the virus:- Variant B.1.617.1 * It was first discovered last year in October in India. *The variant is further mutating and one of its sub-lineages, the B.1.617.2, reported in India, is more infectious than its parent and fast increasing its footprint, according to Rakesh Mishra, former Director of the Centre for Cellular and Molecular Biology. * It has been f...

‘Never exported vaccines at the cost of people in India’ IANS / Updated: May 19, 2021, 06:00 IST Under pressure to prioritise India’s needs during second wave, SII CEO Adar Adar Poonawalla has clarified that the SII never exported vaccines at the cost of the people in India. Defending the move to export vaccines earlier this year by the government and vaccine manufacturers which has been the subject of a heated debate, he said: “Another important factor that people do not tend to rea...

India approves Roches antibody cocktail to treat COVID-19; Cipla to distribute the drug The approval was granted by the Central Drugs Standards Control Organisation (CDSO) basis data filed with the US regulators as well as the scientific opinion of a European regulatory panel BusinessToday.In | May 6, 2021 | Updated 09:53 IST A logo of Swiss pharmaceutical company Roche in Rotkreuz, Switzerland, April 12, 2012. (Photo: Reuters) Pharma giant Roche India has received the Emergency Use Authorisat...

May 05, 2021 Company to partner with Cipla for pan-India distribution Roche India on Wednesday received Emergency User Authorisation (EUA) from regulator - Central Drugs Standards Control Organisation (CDSCO) for antibody cocktail (Casirivimab and Imdevimab) to be used for treatment of mild to moderate Covid-19 in adults and kids aged 12 years or older in India. The approval was based on the data filed for the EUA in the United States and the scientific opinion of the Committee for Medicinal...

06:30am EDT| AbCellera’s Billionaire CEO Says New Covid Treatment Could Be A ‘Game Changer’ As Global Cases Rise Share to Facebook Jens Kristian Balle/The Forbes Collection The company’s new antibody treatment, which is heading to clinical trials, works against variants and may be potent enough to be used in areas without a strong medical infrastructure. In a news briefing Monday, WHO Director-General Tedros Gheybeyesus said that in the last two weeks, there’ve been mo...

NEW DELHI: Amid a sudden surge in hospitalisation of Covid-19 patients resulting in a high demand for Tocilizumab, the Centre has made an interim allocation of the drug among states as a fresh limited stock of the drug has arrived in the country. Tocilizumab, manufactured by Roche, is imported and distributed by Cipla in India. In a joint letter to states, the department of pharma and health ministry said the drug went out of stock a few weeks ago due to a sudden surge in its demand. “Fresh...

Zydus Ahmedabad based Zydus Cadila Healthcare has started advance production of its under-trial DNA plasmid COVID-19 vaccine, even though it will be seeking an emergency use authorisation for the same in May or June, reports Livemint. The company is aiming to produce as many as 240 million doses per annum of its vaccine candidate ZyCoV-D. However, it should be noted that even though the company has begun producing the vaccine doses, the production right now is not "meaningfully large", accordi...

Zydus In a big boost to the national effort against COVID-19, Ahmedabad-based pharmaceutical major Zydus Cadila on Friday (23 April) announced that the company has received Restricted Emergency Use Approval (EUA) from the Drug Controller General of India (DCGI) for the use of ‘Virafin’, Pegylated Interferon alpha-2b (PegIFN,) in treating moderate COVID-19 infection in adults. The company has claimed that a single dose subcutaneous regimen of the Virafin developed by it can help patien...